Concepedia

Shunji Yamazaki

SY

14

Publications

770

Citations

13

H-Index

1994

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Mochida Pharmaceutical (Japan)

The University of Osaka

Hamamatsu Photonics (Japan)

Fujisawa City Hospital

Shunji Yamazaki is an author at Astellas Pharma (Japan) specializing in medicine, pharmacology, and neuroscience.

Top concepts

Publications per year

1994–2016

14

Publications

14

Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins

Masahiro Sugimoto, Ichirō Uchida, Takashi Mashimo et al. · Neuropharmacology · 2003 · 192 citations

, , +8

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

Akinori Iwashita, Yuko Muramatsu, Takao Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 140 citations

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats

Yuka Hayashizaki-Someya, Eiji Kurosaki, Toshiyuki Takasu et al. · European Journal of Pharmacology · 2015 · 108 citations

, , +15

A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model

Misato Ito, Shunji Yamazaki, Kaoru Yamagami et al. · Journal of Pharmacological Sciences · 2016 · 91 citations · Full text

, , +17

The <i>β</i>‐lactam antibiotics, penicillin‐G and cefoselis have different mechanisms and sites of action at GABA<sub>A</sub> receptors

Masahiro Sugimoto, Sakae Fukami, Hiroshi Kayakiri et al. · British Journal of Pharmacology · 2002 · 59 citations · Full text

Rows per page

1–5 of 14